by Alex Perry | Feb 10, 2026 | General
Shares of Nektar Therapeutics (NASDAQ:NKTR) are soaring Tuesday following a significant update regarding the company’s atopic dermatitis treatment. Nektar Therapeutics stock is among today’s top performers. What’s behind NKTR gains? Positive Dermatitis Treatment Data...
by Avi Kapoor | Feb 10, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. B. Riley Securities analyst Anderson Schock initiated coverage on...
by Lekha Gupta | Feb 10, 2026 | General
Robo.ai Inc. (NASDAQ:AIIO) shares are up on Tuesday after the company announced a joint venture with DaBoss.AI Inc. in the UAE to build a distributed embodied-intelligence data acquisition and annotation center. The partnership is designed to tackle persistent...
by Akanksha Bakshi | Feb 10, 2026 | General
DuPont de Nemours, Inc. (NYSE:DD) reported its fourth-quarter 2025 results on Tuesday, posting net sales of $1.7 billion, unchanged from the prior year, with organic sales down 1%. Sales reached $1.693 billion, edging past the $1.688 billion consensus estimate. The...
by Parshwa Turakhiya | Feb 10, 2026 | General
U.S. Bitcoin (CRYPTO: BTC) ETFs recorded back-to-back inflows totaling $616 million for the first time in a month, yet total holdings dipped only 6% despite Bitcoin’s 50% crash as BTC tests critical $68,000 support. The Institutional Conviction Bitcoin ETFs registered...
Recent Comments